WuXi Biologics block fetches HK$6.1bn

biopharma_stocks_adobe_575x375.jpg
By Jonathan Breen
02 Sep 2020

WuXi Biologics Holdings has raised HK$6.1bn ($787.5m) after selling a block of shares in WuXi Biologics (Cayman), the fourth time it has trimmed its position in the company this year.

The vendor – which is controlled by Ge Li, chairman of WuXi Biologics – hit the market after Hong Kong trading hours on Tuesday, offering 33m of its shares in the Chinese biotechnology firm, equal to 2.43% of its total share capital.

Sole placing agent Morgan Stanley marketed ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial